(Q53894459)

22 May 2018

title

Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series. (English)

1 reference

22 May 2018

author name string

Sharma V

series ordinal

1

1 reference

22 May 2018

publication date

1 April 2001

1 reference

22 May 2018

Journal of Affective Disorders

published in

1 reference

22 May 2018

volume

64

1 reference

22 May 2018

issue

1

1 reference

22 May 2018

page(s)

99-106

1 reference

22 May 2018

Affective disorders in referred children and younger siblings of manic-depressives. Mode of onset and prospective course

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Fluoxetine efficacy in treatment resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Loss of Antidepressant Efficacy During Maintenance Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Psychiatrists' responses to failure of maintenance therapy with antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

A proposed new approach to the clinical subclassification of depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Change in serum antidepressant level at a constant dose of medication

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Tolerance to therapeutic effects of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Mood stabilizer combinations: a review of safety and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Antidepressant tachyphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Bromocriptine Treatment of Relapses Seen During Selective Serotonin Re-uptake Inhibitor Treatment of Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Lithium in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Combination of fluoxetine with pemoline in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Outcome of depression in psychiatric settings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Antidepressant effects of carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Loss of drug effects during continuation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Further evidence that a placebo response to antidepressants can be identified

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Postpartum psychoses in patients with manic depressive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Lithium as a prophylactic agent in unipolar affective illness: comparison with cyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

Is delusional depression related to bipolar disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

The course of depression in adult outpatients. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900212-3

7 January 2021

10.1016/S0165-0327(00)00212-3

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018